DiscoverFrom Lab to LifeImpact of PBC Treatment and ​Low Initiation Rates in PBC Therapy
Impact of PBC Treatment and ​Low Initiation Rates in PBC Therapy

Impact of PBC Treatment and ​Low Initiation Rates in PBC Therapy

Update: 2024-09-25
Share

Description

For CME Information & Credit Visit: https://www.iridiumce.com/leveling-up-pbc-podcast-1

Summary:

This conversation focuses on Primary Biliary Cholangitis (PBC), discussing its diagnosis, differentiation from other liver diseases, and evolving treatment paradigms. The speakers emphasize the importance of personalized care and a multidisciplinary approach to manage the systemic complications associated with PBC. They also explore a real-world case study to illustrate the application of these principles in patient management.

Takeaways:

  • PBC is diagnosed through serologic tests and imaging.
  • Differentiating PBC from other liver diseases is crucial.
  • Current treatment involves UDCA, but many patients are unresponsive.
  • New treatment paradigms focus on personalized care.
  • Multidisciplinary teams are essential for managing PBC complications.
  • Obetacolic acid and L-epipneuronal are new treatment options.
  • Patient compliance with medication is critical for treatment success.
  • Systemic complications of PBC include osteoporosis and vitamin deficiencies.
  • Challenges in PBC management include physician awareness and patient education.
  • Personalized care can enhance patient outcomes in PBC management.


Sound Bites:

  • "PBC is fairly straightforward to diagnose."
  • "The current paradigm is once you diagnose PBC."
  • "The new paradigm is more of a personalized care."


Clinical Resource Tool: https://www.iridiumce.com/leveling-up-pbc-management-resource 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Impact of PBC Treatment and ​Low Initiation Rates in PBC Therapy

Impact of PBC Treatment and ​Low Initiation Rates in PBC Therapy

Iridium Continuing Education